Latest Breaking News On - Every test - Page 3 : comparemela.com
Langer rejects Smith s captaincy ambitions | Warwick Daily News
warwickdailynews.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from warwickdailynews.com.au Daily Mail and Mail on Sunday newspapers.
Langer rejects Smith s captaincy ambitions
themorningbulletin.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themorningbulletin.com.au Daily Mail and Mail on Sunday newspapers.
Langer rejects Smith s captaincy ambitions
gympietimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gympietimes.com.au Daily Mail and Mail on Sunday newspapers.
Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering
News provided by
Share this article
Share this article
RARITAN, N.J., Jan. 27, 2021 /PRNewswire/ Ortho Clinical Diagnostics Holdings plc ( Ortho ), the world s largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the pricing of its initial public offering of 76 million ordinary shares at $17.00 per share. The gross proceeds raised from this offering are expected to be $1,292 million. Ortho s ordinary shares are expected to begin trading on The Nasdaq Global Select Market on January 28, 2021, under the symbol OCDX, and the offering is expected to close on February 1, 2021, subject to customary closing conditions.
Ortho Clinical Diagnostics Announces Launch of Initial Public Offering
RARITAN, N.J., Jan. 19, 2021 /PRNewswire/ Ortho Clinical Diagnostics Holdings plc ( Ortho ), the world s largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the launch of its initial public offering of its ordinary shares. Ortho is offering 70 million ordinary shares, with the initial public offering price expected to be between $20.00 and $23.00 per share.
Ortho expects to grant the underwriters a 30-day option to purchase up to 10.5 million additional ordinary shares at the initial public offering price less underwriting discounts and commissions. Ortho has applied to have its ordinary shares approved for listing on The NASDAQ Stock Market under the symbol OCDX.